Increasing Incidence of Osteoarthritis and Osteoporosis Driving Collagen Peptide Market, Finds Frost & Sullivan
26 Jun, 2012, 13:04 BST
- Market propelled further by manufacturers investing on research and development to prove product efficacy
MOUNTAIN VIEW, California, June 26, 2012 /PRNewswire/ -- One of the main challenges faced by the collagen peptide industry is fierce competition from established ingredients like chondroitin sulfate and glucosamine. Manufacturers, however, are combating this situation by conducting numerous studies in order to prove the efficacy of collagen peptides and show the benefits of combining peptides with other ingredients.
New analysis from Frost & Sullivan (http://www.food.frost.com), Strategic Analysis of the Collagen Peptide Market in the United States, finds that the market earned revenues of $224.6 million in 2011. It is expected to increase to $344.5 million by 2017.
If you are interested in more information on this research, please send an email to Jeannette Garcia, Corporate Communications, at jeannette.garcia@frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
The increasing incidence of osteoporosis and osteoarthritis, combined with an aging population globally, promises a great growth potential for collagen peptides.
"Collagen peptides have the ability to cure bone- and joint-related ailments without causing any side effects," said Research Associate Ashwin Raj Ravinder. "Moreover, the protein is known for its use in cosmetic applications to retain a youthful appearance. Both characteristics will help manufacturers garner a greater penetration."
The constantly increasing demand to stay young is accomplished by consuming collagen peptides within functional foods and beverages, as well as in dietary supplements. The concept of blending collagen peptides with first generation ingredients, such as chondroitin, has caused a boom in the market.
None the less, there is a lower awareness amongst consumers to want collagen peptide enriched products because there is a lack of health claims that support the benefits of the ingredient. Manufacturers should invest on more research and development, marketing and conducting human clinical studies to prove the efficacy of collagen peptides.
"Manufacturers must look at blending collagen peptides with other well-known, complementary ingredients in the market like chondroitin and glucosamine in order to gain a significant market share," said Ravinder. "Increasing marketing activities and creating awareness amongst consumers is always essential."
Strategic Analysis of the Collagen Peptide Market in the United States is part of the Food & Beverage Growth Partnership Services program, which also includes research in the following markets: US Bone & Joint Health Ingredients Market and European Bone & Joint Health Ingredients Market, U.S. Market for Nutritional Solutions in Women's Health, Trends and Opportunities in the U.S. Food Fibers Market, and Analysis of the Shelf-life Food Additives Market, among others. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Strategic Analysis of the Collagen Peptide Market in the United States N9F1-88
Contact:
Jeannette Garcia
Corporate Communications – North America
P: 210.477.8427
E: jeannette.garcia@frost.com
SOURCE Frost & Sullivan